Send to

Choose Destination
See comment in PubMed Commons below
J Am Acad Nurse Pract. 2012 Jul;24(7):417-24. doi: 10.1111/j.1745-7599.2012.00704.x. Epub 2012 Mar 30.

Current guidelines for cervical cancer screening.

Author information

  • 1University of Massachusetts Amherst, Amherst, Massachusetts University of Massachusetts Boston, Boston, Massachusetts 01003, USA.



To provide evidence-based information that will guide nurse practitioners in instituting the most current cervical cancer screening recommendations.


A literature search covering the years 2006 to the present conducted through Medline, CINAHL, and OVID.


Human papillomavirus (HPV) cervical infections are highly prevalent among females under 21 years, yet this age group has a low incidence of cervical cancer. For young women, 90% of HPV infections regress in 24 months, and, in longitudinal studies, no invasive cervical cancer was detected. HPV co-testing is effective for women age 30 and over.


Current scientific evidence supports initiating cervical cancer screening for immunocompetent women at age 21, biennial screening between ages 21 and 29, and HPV DNA co-testing for women over 30. Nurse practitioners play an important role in integrating the newest guidelines into practice and improving the quality of healthcare regarding women's cervical health and cancer prevention.

©2012 The Author(s) Journal compilation ©2012 American Academy of Nurse Practitioners.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk